Efficacy and safety of once‐weekly semaglutide in Japanese individuals with type 2 diabetes in the SUSTAIN 1, 2, 5 and 9 trials: Post‐hoc analysis

AIMS/INTRODUCTION: The etiology and treatment of type 2 diabetes might differ between specific populations. This post‐hoc exploratory analysis assessed the efficacy and safety of once‐weekly subcutaneous semaglutide vs comparators in Japanese individuals with type 2 diabetes in comparison with the t...

Descripción completa

Detalles Bibliográficos
Autores principales: Araki, Eiichi, Harashima, Shinichi, Nishida, Tomoyuki, Nakamura, Jiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720207/
https://www.ncbi.nlm.nih.gov/pubmed/36222597
http://dx.doi.org/10.1111/jdi.13905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720207/
https://www.ncbi.nlm.nih.gov/pubmed/36222597
http://dx.doi.org/10.1111/jdi.13905

Ejemplares similares